Development and Validation of Stability-Indicating Assay Method for a Novel Oxazolidinone (PH-192) with Anticonvulsant Activity by Using UHPLC-QToF-MS

The treatment of seizure disorders with currently available pharmacotherapeutic agents is not optimal due to the failure of some patients to respond, coupled with occurrences of side effects. There is therefore a need for research into the development of new chemical entities as potential anticonvul...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Tannak, Naser F., Phillips, Oludotun A., Kamal, Husein J., Hemdan, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840153/
https://www.ncbi.nlm.nih.gov/pubmed/35164353
http://dx.doi.org/10.3390/molecules27031090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840153/
https://www.ncbi.nlm.nih.gov/pubmed/35164353
http://dx.doi.org/10.3390/molecules27031090

Ejemplares similares